One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Diabetes-related complications: a toll too high
doi : 10.1016/S2213-8587(24)00246-8
Volume 12, Issue 9, September 2024, Page 601
Prediabetes remission in people with obesity
Michael Bergman a
Sex differences in familial hypercholesterolaemia
Xavier Rossello a b c d, Francisca Caimari a
Implementing type 2 diabetes remission interventions in the real world: what have we learnt?
Srikanth Bellary a b
A roadmap for integrating mental health and diabetes services
Khalida Ismail a c d, Marietta Stadler c d, Melissa Holloway b, Jonathan Valabhji e
The evidence for achondroplasia in 1st century AD Italy
Francesco M Galassi a, Laura Landini b, Kristina Killgrove c, Marco Artico d, Lorenzo Rossi e, Veronica Papa b f, Elena Varotto g h
Risk of new-onset diabetes with high-intensity statin use
David M Diamond a, Kevin E Kip b
Reasons to not rethink the label anti-obesity medication
Richard Armitage
Food additive emulsifiers and risk of type 2 diabetes
Jieling Chen a, Suilian Zheng a
Food additive emulsifiers and risk of type 2 diabetes
Ying Cui a
Food additive emulsifiers and risk of type 2 diabetes
Xi Fu a, Yiwen Yuan b c, Yiqun Deng b d, Yu Sun b c
Food additive emulsifiers and risk of type 2 diabetes – Authors' reply
Bernard Srour a b, Clara Salame a, Mathilde Touvier a b
Embracing community sport to promote global health
Nikolaj Gilbert a, Oliver Dudfield b, Fiona Bull c
Iodine deficiency in Europe: vigilance and action required
Talha Burki
Correction to Lancet Diabetes Endocrinol 2024; published online July 22. https://doi.org/10.1016/S2213-8587(24)00163-3
Correction to Lancet Diabetes Endocrinol 2024; published online July 19. https://doi.org/10.1016/S2213-8587(24)00157-8
Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries
Chunxiao Li PhD a, Tom R P Bishop ME a, Fumiaki Imamura PhD a, Stephen J Sharp MSc a, Matthew Pearce PhD a, Soren Brage PhD a, Prof Ken K Ong FRCPCH a, Prof Habibul Ahsan MD b, Prof Maira Bes-Rastrollo PhD c, Prof Joline W J Beulens PhD d e, Nicole den Braver PhD d e, Prof Liisa Byberg PhD f, Scheine Canhada PhD g, Prof Zhengming Chen DPhil h i, Hsin-Fang Chung PhD j, Adrian Cortés-Valencia PhD k, Luc Djousse MD l m n, Jean-Philippe Drouin-Chartier PhD q, Huaidong Du PhD h i, Prof Shufa Du PhD r…Prof Nicholas J Wareham FMedSci a â€
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
Prof Barbara M McGowan MD a, Prof Jens M Bruun MD b, Matt Capehorn MB c, Sue D Pedersen MD d, Prof Kirsi H Pietiläinen MD e f, Hanna Angelene Kudiyanur Muniraju MSc g, Maria Quiroga MD h, Anette Varbo MD h, Prof David C W Lau MD i, STEP 10 Study Group â€
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort study
Leopoldo Pérez de Isla PhD a b *, Antonio J Vallejo-Vaz PhD c d e *, Prof Gerald F Watts DSc f g, Ovidio Muñiz-Grijalvo PhD d h, Rodrigo Alonso PhD b i, Jose L Diaz-Diaz PhD J, Raquel Arroyo-Olivares PhD b, Rocio Aguado PhD k, Rosa Argueso PhD l, Marta Mauri PhD m, Manuel J Romero PhD n, Pilar Ã�lvarez-Baños PhD o, Dolores Mañas PhD p, José MarÃa Cepeda MD q, Pablo Gonzalez-Bustos MD r, Marta Casañas PhD s, Alfredo Michan PhD t, Prof Juan F Sánchez Muñoz-Torrero PhD u, Ceferino Faedo PhD v, Prof Miguel A Barba PhD w…Pedro Mata PhD b
Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation
Prof Jonathan Valabhji MD a b c, Tessa Gorton BSc a, Emma Barron MSc a b c, Soraya Safazadeh MSc a, Fiona Earnshaw PhD a, Clare Helm BSc a, Martin Virr BA a, John Kernan BSc a, Shaun Crowe BA a, Prof Paul Aveyard PhD d, Prof John Wilding MD e, Tony Willis PhD f, Prof Louisa Ells PhD g, Simon O'Neill RN h, Elizabeth Robertson PhD h, Prof Susan Jebb PhD d, Prof Roy Taylor MD i, Chirag Bakhai MBA a j
Understanding the cause of type 2 diabetes
Prof Roy Taylor MD a b
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Muhammad Abdul-Ghani MD PhD a, Pietro Maffei MD b, Ralph Anthony DeFronzo MD a
